First Time Loading...

Fate Therapeutics Inc
NASDAQ:FATE

Watchlist Manager
Fate Therapeutics Inc Logo
Fate Therapeutics Inc
NASDAQ:FATE
Watchlist
Price: 4.195 USD 2.82% Market Closed
Updated: May 13, 2024

Fate Therapeutics Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fate Therapeutics Inc
Pre-Tax Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Fate Therapeutics Inc
NASDAQ:FATE
Pre-Tax Income
-$160.9m
CAGR 3-Years
2%
CAGR 5-Years
-19%
CAGR 10-Years
-23%
Abbvie Inc
NYSE:ABBV
Pre-Tax Income
$6.3B
CAGR 3-Years
23%
CAGR 5-Years
4%
CAGR 10-Years
2%
Gilead Sciences Inc
NASDAQ:GILD
Pre-Tax Income
$1.1B
CAGR 3-Years
-18%
CAGR 5-Years
-33%
CAGR 10-Years
-16%
Amgen Inc
NASDAQ:AMGN
Pre-Tax Income
$4.3B
CAGR 3-Years
-18%
CAGR 5-Years
-14%
CAGR 10-Years
-2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Pre-Tax Income
$4.4B
CAGR 3-Years
12%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Pre-Tax Income
$4B
CAGR 3-Years
-3%
CAGR 5-Years
10%
CAGR 10-Years
18%

See Also

What is Fate Therapeutics Inc's Pre-Tax Income?
Pre-Tax Income
-160.9m USD

Based on the financial report for Dec 31, 2023, Fate Therapeutics Inc's Pre-Tax Income amounts to -160.9m USD.

What is Fate Therapeutics Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
-23%

Over the last year, the Pre-Tax Income growth was 43%. The average annual Pre-Tax Income growth rates for Fate Therapeutics Inc have been 2% over the past three years , -19% over the past five years , and -23% over the past ten years .